Profil
Daniel J.
Kerkman, Ph.D., joined the Company in August 1993 as Group Leader of Chemistry and now serves in his role of Vice President, Research.
Prior to joining the Company, Dr. Kerkman spent thirteen years at Abbott Laboratories where he began his career as a research chemist initially in the cardiovascular area followed by several positions within both the immunoscience and neuroscience areas.
A series of promotions ended with his position as the Project Leader in Adrenergic research within the Pharmaceutical Products Division supervising a 35 person staff.
During his tenure, a number of IND candidates were identified.
Dr. Kerkman received his Ph.D.
degree from MIT in 1979 and worked one year as a postdoctoral fellow in the Department of Chemistry at MIT.
He is co-author on more than 40 scientific publications and holds 16 U.S.
patents.
Ehemalige bekannte Positionen von Daniel J. Kerkman
Unternehmen | Position | Ende |
---|---|---|
Applied NeuroSolutions, Inc.
Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Daniel J. Kerkman
Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Applied NeuroSolutions, Inc.
Applied NeuroSolutions, Inc. BiotechnologyHealth Technology Applied NeuroSolutions, Inc. is a development stage biopharmaceutical company that engages in the research and development of a diagnostic tests to detect and novel therapeutics to treat Alzheimer's disease in humans. It researches and develops pharmaceuticals with an emphasis on products for infectious, inflammatory and other diseases. The company was founded on March 14, 1992 and is headquartered in Vernon Hills, IL. | Health Technology |